The HOXB4 Homeoprotein promotes the ex vivo enrichment of functional human embryonic stem cell-derived NK cells

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Larbi, Aniya ^a   Gombert, Jean Marc ^b   Auvray, Céline ^c,d,e   l'Homme, Bruno ^f   Magniez, Aurélie ^a   Féraud, Olivier ^a   Coulombel, Laure ^a   Chapel, Alain ^f   Mitjavila Garcia, Maria Teresa ^a   Turhan, Ali G ^a,b   Haddad, Rima ^a,g   Bennaceur Griscelli, Annelise ^a,g,h  

^a Centre National de la Recherche Scientifique   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c INSTITUT COCHIN   (France)

^d CNRS   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

^h HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RA ANTIGEN; GAMMA INTERFERON; HOMEODOMAIN PROTEIN; HOMEODOMAIN PROTEIN HOXB4; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

ARTICLE; CD34 SELECTION; CELL DIFFERENTIATION; CELL FUNCTION; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; EMBRYONIC STEM CELL; ENRICHMENT CULTURE; EX VIVO STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PROTEIN FUNCTION; STEM CELL EXPANSION; STROMA CELL;

CELL DIFFERENTIATION; CELL LINE; COCULTURE TECHNIQUES; EMBRYONIC STEM CELLS; HOMEODOMAIN PROTEINS; HUMANS; KILLER CELLS, NATURAL; STROMAL CELLS; TRANSCRIPTION FACTORS;

EID: 84863009763     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039514     Document Type: Article

References (55)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
2. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A, (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18: 399-404.
3. Melief CJ, Toes RE, Medema JP, van der Burg SH, Ossendorp F, et al. (2000) Strategies for immunotherapy of cancer. Adv Immunol 75: 235-282.
4. Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA, (2001) Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 98: 10716-10721.
5. Chadwick K, Wang L, Li L, Menendez P, Murdoch B, et al. (2003) Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102: 906-915.
6. Tian X, Morris JK, Linehan JL, Kaufman DS, (2004) Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cells. Exp Hematol 32: 1000-1009.
7. Zhan X, Dravid G, Ye Z, Hammond H, Shamblott M, et al. (2004) Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. Lancet 364: 163-171.
8. Vodyanik MA, Bork JA, Thomson JA, Slukvin II, (2005) Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 105: 617-626.
9. Wang Y, Yates F, Naveiras O, Ernst P, Daley GQ, (2005) Embryonic stem cell-derived hematopoietic stem cells. Proc Natl Acad Sci U S A 102: 19081-19086.
10. Zambidis ET, Peault B, Park TS, Bunz F, Civin CI, (2005) Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 106: 860-870.
11. Bowles KM, Vallier L, Smith JR, Alexander MR, Pedersen RA, (2006) HOXB4 overexpression promotes hematopoietic development by human embryonic stem cells. Stem Cells 24: 1359-1369.
12. Vodyanik MA, Thomson JA, Slukvin II, (2006) Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 108: 2095-2105.
13. Lu SJ, Feng Q, Ivanova Y, Luo C, Li T, et al. (2007) Recombinant HoxB4 fusion proteins enhance hematopoietic differentiation of human embryonic stem cells. Stem Cells Dev 16: 547-559.
14. Woan K, Reddy V, (2007) Potential therapeutic role of natural killer cells in cancer. Expert Opin Biol Ther 7: 17-29.
15. Ma F, Ebihara Y, Umeda K, Sakai H, Hanada S, et al. (2008) Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proc Natl Acad Sci U S A 105: 13087-13092.
16. Woll PS, Martin CH, Miller JS, Kaufman DS, (2005) Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity. J Immunol 175: 5095-5103.
17. Woll PS, Grzywacz B, Tian X, Marcus RK, Knorr DA, et al. (2009) Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo anti-tumor activity. Blood.
18. Pelayo R, Welner R, Perry SS, Huang J, Baba Y, et al. (2005) Lymphoid progenitors and primary routes to becoming cells of the immune system. Curr Opin Immunol 17: 100-107.
19. Elliott JM, Wahle JA, Yokoyama WM, (2010) MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. The Journal of experimental medicine 207: 2073-2079.
20. Antonchuk J, Sauvageau G, Humphries RK, (2002) HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109: 39-45.
21. Buske C, Feuring-Buske M, Abramovich C, Spiekermann K, Eaves CJ, et al. (2002) Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells. Blood 100: 862-868.
22. Amsellem S, Pflumio F, Bardinet D, Izac B, Charneau P, et al. (2003) Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat Med 9: 1423-1427.
23. Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, et al. (2003) In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med 9: 1428-1432.
24. Schiedlmeier B, Klump H, Will E, Arman-Kalcek G, Li Z, et al. (2003) High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation. Blood 101: 1759-1768.
25. Zhang XB, Beard BC, Beebe K, Storer B, Humphries RK, et al. (2006) Differential effects of HOXB4 on nonhuman primate short- and long-term repopulating cells. PLoS Med 3: e173.
26. Haddad R, Pflumio F, Vigon I, Visentin G, Auvray C, et al. (2008) The HOXB4 homeoprotein differentially promotes ex vivo expansion of early human lymphoid progenitors. Stem Cells 26: 312-322.
27. Helgason CD, Sauvageau G, Lawrence HJ, Largman C, Humphries RK, (1996) Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro. Blood 87: 2740-2749.
28. Kyba M, Perlingeiro RC, Daley GQ, (2002) HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109(1): 29-37.
29. Pilat S, Carotta S, Schiedlmeier B, Kamino K, Mairhofer A, et al. (2005) HOXB4 enforces equivalent fates of ES-cell-derived and adult hematopoietic cells. Proc Natl Acad Sci U S A 102: 12101-12106.
30. Chan KM, Bonde S, Klump H, Zavazava N, (2008) Hematopoiesis and immunity of HOXB4-transduced embryonic stem cell-derived hematopoietic progenitor cells. Blood 111: 2953-2961.
31. Lee GS, Kim BS, Sheih JH, Moore M, (2008) Forced expression of HoxB4 enhances hematopoietic differentiation by human embryonic stem cells. Mol Cells 25: 487-493.
32. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, et al. (1996) Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. The Journal of biological chemistry 271: 18188-18193.
33. Haddad R, Caignard A, Visentin G, Vigon I, Fichelson S, et al. (2007) The HOXB4 homeoprotein improves ex vivo generation of functional human NK-cell progenitors. Leukemia 21: 1836-1839.
34. Goldman O, Feraud O, Boyer-Di Ponio J, Driancourt C, Clay D, et al. (2009) A boost of BMP4 accelerates the commitment of human embryonic stem cells to the endothelial lineage. Stem Cells 27: 1750-1759.
35. Itoh K, Tezuka H, Sakoda H, Konno M, Nagata K, et al. (1989) Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Experimental hematology 17: 145-153.
36. Issaad C, Croisille L, Katz A, Vainchenker W, Coulombel L, (1993) A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38- progenitor cells in long-term cultures and semisolid assays. Blood 81: 2916-2924.
37. Klein E, Ben-Bassat H, Neumann H, Ralph P, Zeuthen J, et al. (1976) Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer 18: 421-431.
38. Grossman WJ, Verbsky JW, Tollefsen BL, Kemper C, Atkinson JP, et al. (2004) Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104: 2840-2848.
39. Nasef A, Mazurier C, Bouchet S, Francois S, Chapel A, et al. (2008) Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. Cell Immunol 253: 16-21.
40. Kenneth JL & Thomas DS, (2001) Analysis of relative gene expression data using relative time quantitative PCR and 2DDCt. Methods 25: 402-408.
41. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, et al. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146.
42. Auvray C, Delahaye A, Pflumio F, Haddad R, Amsellem S,et al. HOXC4 homeoprotein efficiently expands human hematopoietic stem cells and triggers similar molecular alterations as HOXB4. Haematologica 97: 168-178.
43. Deneault E, Cellot S, Faubert A, Laverdure JP, Frechette M, et al. (2009) A functional screen to identify novel effectors of hematopoietic stem cell activity. Cell 137: 369-379.
44. Oshima M, Endoh M, Endo TA, Toyoda T, Nakajima-Takagi Y, et al. (2011) Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells. Blood 117: e142-150.
45. Galy A, Travis M, Cen D, Chen B, (1995) Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3: 459-473.
46. Haddad R, Guardiola P, Izac B, Thibault C, Radich J, et al. (2004) Molecular characterization of early human T/NK and B-lymphoid progenitor cells in umbilical cord blood. Blood 104: 3918-3926.
47. Haddad R, Guimiot F, Six E, Jourquin F, Setterblad N, et al. (2006) Dynamics of thymus-colonizing cells during human development. Immunity 24: 217-230.
48. Doulatov S, Notta F, Eppert K, Nguyen LT, Ohashi PE, et al. (2010) Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol 11: 585-593.
49. Doulatov S, Notta F, Laurenti E, Dick JE, (2012) Hematopoiesis: a human perspective. Cell Stem Cell 10: 120-136.
50. Bourgeois E, Van LP, Samson M, Diem S, Barra A, et al. (2009) The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol 39: 1046-1055.
51. Tashiro K, Kawabata K, Omori M, Yamaguchi T, Sakurai F, et al. (2012) Promotion of hematopoietic differentiation from mouse induced pluripotent stem cells by transient HoxB4 transduction. Stem cell research 8: 300-311.
52. Knorr DA, Kaufman DS Pluripotent stem cell-derived natural killer cells for cancer therapy. Transl Res 156(3): 147-154.
53. Yong AS, Keyvanfar K, Hensel N, Eniafe R, Savani BN, et al. (2009) Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib. Blood 113: 875-882.
54. Schiedlmeier B, Santos AC, Ribeiro A, Moncaut N, Lesinski D, et al. (2007) HOXB4's road map to stem cell expansion. Proceedings of the National Academy of Sciences of the United States of America 104: 16952-16957.
55. Milsom MD, Schiedlmeier B, Bailey J, Kim MO, Li D, et al. (2009) Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cells. Blood 113: 5111-5120.